June 29, 2022

Volume XII, Number 180


June 29, 2022

Subscribe to Latest Legal News and Analysis

June 28, 2022

Subscribe to Latest Legal News and Analysis

June 27, 2022

Subscribe to Latest Legal News and Analysis

7 Hot Health Care Industry Sectors for Investment, Growth & Consolidation in 2020

Epstein Becker Green attorneys and strategic advisors from EBG Advisors are predicting the “hot” health care sectors for investment, growth, and consolidation in 2020.  These predictions for 2020 are largely based on the increasing confluence of the following three key “drivers” of health industry transformation that is substantially underway:

  1. The ongoing national imperative of reducing the cost of health care, via disease prevention and detection, and cost-effective, quality treatment, including more efficient care in ambulatory and retail settings;

  2. Extraordinary advances in technologies which enhance disease prevention, detection and cost-effective treatment (e.g., artificial intelligence (AI)-driven diagnosis and treatment, virtual care, electronic medical record (EMR) systems, medical devices, gene therapy, and precision medicine); and

  3. The aging baby-boomer population, with tens of millions of Americans entering into their 70s, 80s, and above.

Hot Sectors

  1. Health Care Information Technology: Advances in analytics and science are key to aiding health care providers in the early detection and treatment of health care conditions and safely delivering quality, lower-cost care. This includes, for example:

    1. Advanced, interoperable EMR systems;

    2. AI and data analytics technologies that improve diagnostics and early detection, enhance the speed of research, development and clinical trials, and guide more effective treatments;

    3. Virtual care (telemedicine) platforms that enhance access to care and treatment in the ever-increasing digital, personal device, and consumer-driven health care economy;

    4. Mobile apps and IT “connected” medical devices that enhance prevention and detection of illnesses, and can guide care for individuals managing chronic diseases; and

    5. Cybersecurity to protect our health information and technology-dependent health care delivery system.

  1. Medical Device and Pharmaceutical: New scientific discoveries are being developed at a fast pace, all of which are geared to more effectively treating health care conditions with an eye towards lower costs (and which are being accelerated by many of the IT advances described above), such as:

    1. Gene therapies, based on research of the human genome;

    2. Precision (personalized) medical treatments; and

    3. New biological drugs based on advanced, AI-driven clinical research and trials.

  1. Physician Services: Physicians are key “quarterbacks” in controlling health care costs, but they require the support of advanced EMR, data analytics, and a vast infrastructure, all of which require substantial capital and the management capabilities of larger organizations. This dynamic is drumming up demand for physicians and competitive offers from the following:

    1. Large national health care companies, both public and private (e.g., Optum, Cigna, Envision, Mednax, etc.)

    2. Physician organizations focused on primary care and managing population health (e.g., Iora, Village MD, Adelaide, etc.);

    3. Large hospital and health care systems;

    4. Mega-groups and specialty platforms backed by private equity (PE) investors; and

    5. Health plans (including HMOs, Medicare Advantage (MA) plans, and clinically integrated IPAs).

  1. Hospitals & Health Systems: Hospital systems, both nonprofit and publicly owned, will get even bigger—both regionally and nationally—in order to increase their available capital and generate economies of scale in connection with their investments in new patient-friendly facilities with advanced ICU and acute care services in addition to capabilities to manage care efficiently. These capabilities include advanced EMR, data analytics, virtual care, urgent care locations, physicians, clinical integration, population health, social determinant initiatives, cutting-edge technologies, and other strategic, scaled corporate infrastructure.

  1. Long-Term Care Services: With the aging baby-boomer demographic, there is increasing demand for all components along the continuum of long-term care services, with a particular focus on providing care at either the patient’s homes (via home health agencies) or at the least costly care setting (e.g., adult day care vs. assisted living vs. skilled nursing facilities).

  1. Behavioral Health Services: There has been increasing awareness of, and funding for, the treatment of the entire range of behavioral health services, including patients within the autism spectrum, with mental health illnesses (e.g., depression, anxiety, etc.), as well as substance use disorders (opioids, alcohol, etc.) and other addiction disorders.

  1. Medicare Advantage Plans: As the number of Medicare enrollees skyrockets and the Medicare program continues to pivot to “accountable” models of care (bundled payments and other risk-based initiatives), more and more Medicare beneficiaries are participating in MA plans. Increased MA plan enrollment is also being driven by regulatory changes governing benefit design that now allow MA plans to provide enhanced benefits to insureds, including prescriptions, eye care, transportation and much more.  MA plans—which receive risk-based reimbursement—will utilize many of the advanced technologies described above to assist in controlling the cost of their enrollees’ care (through, for example, prevention initiatives and chronic care management).

©2022 Epstein Becker & Green, P.C. All rights reserved.National Law Review, Volume X, Number 9

About this Author

Gary Herschman, Epstein Becker Law Firm, Healthcare Attorney

GARY W. HERSCHMAN is a Member of the Firm in the Health Care and Life Sciences practice, in the Newark and New York offices of Epstein Becker Green. He also serves on Epstein Becker Green’s National Health Care and Life Sciences Steering Committee, and prior to joining the firm, Mr. Herschman was Co-Chair of the Health Care Practice Group of a large regional law firm. He is also a member of the firm's Board of Directors.

Mr. Herschman represents a diverse group of health care clients, including health systems, hospitals, nursing...

Mark E. Lutes, Health Care, life Sciences Attorney, Epstein Becker Green, Law Firm

Mark E. Lutes is the Chair of the firm’s Board of Directors and a Member of the firm’s Health Care and Life Sciences practice. Based in Washington, DC, he has practiced with the firm for more than three decades. Prior to that, he was a legislative adviser to the Federal Trade Commission. He also offers strategic counsel in health policy and on reimbursement strategy through the firm's affiliates EBG Advisors, Inc., and National Health Advisors, LLC.

Mr. Lutes is a leader in the firm's representation of private equity and financial services firms...

Bradley Merrill Thompson, Epstein Becker Green, medical drug, device, FDA

 BRADLEY MERRILL THOMPSON is a Member of the Firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory, reimbursement, and clinical trial issues. 

Mr. Thompson regularly defends companies receiving FDA warning letters, on a wide gamut of subjects including good manufacturing practice compliance and off label promotion. He frequently counsels companies on premarket clearance and approval strategies and on marketing strategies. When medical device companies...

Lynn Shapiro Snyder, Epstein Becker Green, Board of Directors
Board of Directors/Member

LYNN SHAPIRO SNYDER is a Senior Member of Epstein Becker Green in the Health Care and Life Sciences and Litigation practices in the firm's Washington, DC, office, and she is Strategic Counsel with EBG Advisors, Inc. Ms. Snyder has over thirty-five years of experience at Epstein Becker Green, advising clients about federal, state, and international health law issues, including Medicare, Medicaid, TRICARE, compliance, and managed care issues. Her clients include health care providers, payors, pharmaceutical/device manufacturers, and those companies and...